Cara Therapeutics Inc (CARA)
0.29
-0.02
(-6.45%)
USD |
NASDAQ |
Nov 22, 09:55
Cara Therapeutics Price to Book Value: 22.50 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 24.05 |
| November 20, 2024 | 23.66 |
| November 19, 2024 | 23.35 |
| November 18, 2024 | 22.69 |
| November 15, 2024 | 24.14 |
| November 14, 2024 | 25.42 |
| November 13, 2024 | 25.15 |
| November 12, 2024 | 26.46 |
| November 11, 2024 | 26.46 |
| November 08, 2024 | 26.37 |
| November 07, 2024 | 26.76 |
| November 06, 2024 | 24.15 |
| November 05, 2024 | 22.57 |
| November 04, 2024 | 22.64 |
| November 01, 2024 | 23.04 |
| October 31, 2024 | 24.08 |
| October 30, 2024 | 22.42 |
| October 29, 2024 | 20.71 |
| October 28, 2024 | 20.95 |
| October 25, 2024 | 20.79 |
| October 24, 2024 | 19.73 |
| October 23, 2024 | 20.64 |
| October 22, 2024 | 20.87 |
| October 21, 2024 | 20.60 |
| October 18, 2024 | 20.57 |
| Date | Value |
|---|---|
| October 17, 2024 | 20.70 |
| October 16, 2024 | 20.56 |
| October 15, 2024 | 19.78 |
| October 14, 2024 | 19.87 |
| October 11, 2024 | 19.44 |
| October 10, 2024 | 19.68 |
| October 09, 2024 | 20.15 |
| October 08, 2024 | 19.87 |
| October 07, 2024 | 20.65 |
| October 04, 2024 | 21.38 |
| October 03, 2024 | 21.41 |
| October 02, 2024 | 22.49 |
| October 01, 2024 | 22.26 |
| September 30, 2024 | 23.89 |
| September 27, 2024 | 1.442 |
| September 26, 2024 | 1.362 |
| September 25, 2024 | 1.313 |
| September 24, 2024 | 1.323 |
| September 23, 2024 | 1.423 |
| September 20, 2024 | 1.428 |
| September 19, 2024 | 1.460 |
| September 18, 2024 | 1.352 |
| September 17, 2024 | 1.263 |
| September 16, 2024 | 1.269 |
| September 13, 2024 | 1.241 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.3789
Minimum
Dec 21 2023
26.76
Maximum
Nov 07 2024
3.536
Average
2.976
Median
Jul 28 2021
Price to Book Value Benchmarks
| Agilent Technologies Inc | 6.411 |
| Seelos Therapeutics Inc | -- |
| Citius Pharmaceuticals Inc | 0.3079 |
| Moleculin Biotech Inc | 1.136 |
| NovaBay Pharmaceuticals Inc | 3.213 |
Price to Book Value Related Metrics
| PS Ratio | 1.825 |
| Price | 0.29 |
| Earnings Yield | -603.4% |
| Market Cap | 15.91M |